Cargando…
Soluble urokinase-type plasminogen activator receptor strongly predicts global mortality in acute heart failure patients: insight from the STADE-HF registry
BACKGROUND: Whether soluble urokinase-type plasminogen activator receptor (suPAR) could be a valuable prognostic indicator remains uncertain. MATERIALS & METHODS: Patients from STADE-HF (Soluble Suppression of Tumorigenesis-2 as a Help for Management of Diagnosis, Evaluation and Management of He...
Autores principales: | Huet, Fabien, Dupuy, Anne-Marie, Duflos, Claire, Reis, Cintia Azara, Kuster, Nils, Aguilhon, Sylvain, Cristol, Jean-Paul, Roubille, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147742/ https://www.ncbi.nlm.nih.gov/pubmed/34046195 http://dx.doi.org/10.2144/fsoa-2020-0197 |
Ejemplares similares
-
STADE‐HF (sST2 As a help for management of HF): a pilot study
por: Huet, Fabien, et al.
Publicado: (2020) -
Multimarker approach including CRP, sST2 and GDF‐15 for prognostic stratification in stable heart failure
por: Kuster, Nils, et al.
Publicado: (2020) -
Multi-Marker Strategy in Heart Failure: Combination of ST2 and CRP Predicts Poor Outcome
por: Dupuy, Anne Marie, et al.
Publicado: (2016) -
Absolute Change in High Sensitivity Cardiac Troponin I for Three Hours is Useful for Diagnosing Acute Myocardial Infarction in the Emergency Department: How to Get to Best Benefit From HS-Troponins in Clinical Practice?
por: Huet, Fabien, et al.
Publicado: (2020) -
Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)